<http://www.reactome.org/biopax/48892Evidence2286> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<http://www.reactome.org/biopax/48892Evidence2286> <http://www.biopax.org/release/biopax-level3.owl#comment> "SMAD2 is polyubiquitinated by SMURF2 and targeted for proteasome-mediated degradation."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://www.reactome.org/biopax/48892Evidence2286> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/11016919> .
<http://www.reactome.org/biopax/48892Evidence2286> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/10458166> .
<http://www.reactome.org/biopax/48892Evidence2286> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/11158580> .
<http://www.reactome.org/biopax/48892Evidence2286> <http://www.biopax.org/release/biopax-level3.owl#evidenceCode> <http://www.reactome.org/biopax/48892EvidenceCodeVocabulary1> .